A New Perspective of Cannabinoid 1 Receptor Antagonists: Approaches Toward Peripheral CB1R Blockers without Crossing the Blood-Brain Barrier

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1421-1429

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment

By Polidori C.   Ciccocioppo R.   Nisato D.   Cazaubon C.   Massi M.  

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 15-21

Elsevier

Access to resources Recommend Favorite

Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adenosine derivatives

By Schaddelee M.P.   Voorwinden H.L.   van Tilburg E.W.   Pateman T.J.   Ijzerman A.P.   Danhof M.   de Boer A.G.  

European Journal of Pharmaceutical Sciences, Vol. 19, Iss. 1, 2003-05 ,pp. : 13-22

Elsevier

Access to resources Recommend Favorite

Blood–brain barrier opening with alkylglycerols: Biodistribution of 1- O -pentylglycerol after intravenous and intracarotid administration in rats

By Erdlenbruch Bernhard   Kugler Wilfried   Schinkhof Claudia   Neurath Hartmud   Eibl Hansjörg   Lakomek Max  

Journal of Drug Targeting, Vol. 13, Iss. 3, 2005-04 ,pp. : 143-150

Informa Healthcare

Access to resources Recommend Favorite

Active efflux of the 5-HT 1A receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier

By van der Sandt I.C.J.   Smolders R.   Nabulsi L.   Zuideveld K.P.   de Boer A.G.   Breimer D.D.  

European Journal of Pharmaceutical Sciences, Vol. 14, Iss. 1, 2001-08 ,pp. : 81-86

Elsevier

Access to resources Recommend Favorite